Moneycontrol PRO
HomeNewsWorldCOVID-19 update | South Korea, a virus success story, is forced to alter its approach

COVID-19 update | South Korea, a virus success story, is forced to alter its approach

I​n the past week, South Korea has begun asking patients who test positive to simply look after themselves at home, while​ the country redirects resources to those who are most vulnerable.

February 18, 2022 / 22:47 IST
Source: Reuters

Source: Reuters

For the past two years, South Korea waged a successful battle against COVID-19 with a so-called three-T strategy: it ramped up lab “tests” to ferret out infections, it “traced” contacts using modern technology, and it “treated” patients by keeping them in quarantine, where they were monitored by the government.

But as the fast-spreading omicron variant threatens to overwhelm the public health system, that strategy now appears unsustainable — and it may even be pointless, South Korean officials say. Now, they are shifting the country’s pandemic focus to a new game plan: “select and focus.”

ALSO READ: South Korea daily COVID-19 cases top 100,000, curfew eased ahead of election

I​n the past week, South Korea has begun asking patients who test positive to simply look after themselves at home, while​ the country redirects resources to those who are most vulnerable. This new approach has unsettled ​people who have grown used to the government’s heavy-handed virus intervention, and as the number of​ people fending for themselves at home has surged, so have the complaints.

Some say they were not put through when they called ​pandemic hotlines seeking information.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Being left alone has felt like “home abandonment” to many.

Medical supplies the government promised to deliver — such as thermometers, oximeters, hand sanitizer and other pandemic necessities — have failed to arrive on time.

“The government’s partially hands-off approach is a shock to people who have dutifully followed what the government told them to do, like wearing masks and getting vaccinated, and in return expected it to take responsibility for protecting their lives,” said Kim Woo-joo, president of the Korean Vaccine Society. “It could feel like a survival-of-the-fittest situation.”

By Tuesday, the government had mobilized thousands of neighborhood clinics to help ease the bottleneck for those seeking help at home. Health officials have tried to reassure people that despite initial disturbances, the recent policy shift was inevitable, compelled — and even justified — by the omicron data.

Until last year, South Korea had never had more than 7,849 new patients a day. But as omicron became the dominant variant, the daily caseload soared to 93,135 on Thursday. The government expects up to 170,000 new patients a day later this month. That is simply too many patients to provide all of them with the same time and attention that it once did.

Fortunately, omicron has proved less dangerous than the delta variant. Even as omicron has surged, the number of COVID-19 fatalities dropped from the daily record of 109 on Dec. 23 to 36 on Thursday. The number of seriously ill patients in hospitals fell from around 1,000 in mid-December to 389 on Thursday. People in their 60s and older accounted for 93% of all fatalities.

“We must use our limited resources more effectively, focusing on preventing high-risk patients from getting seriously ill or dying,” said Health Minister Kwon Deok-cheol.

Under its new strategy, the government will dedicate its monitoring efforts to high-risk patients who are staying at home — those in their 60s and older and people with preexisting medical conditions — supplying them with at-home treatment kits and calling twice a day to check on their condition.

Other patients who test positive must monitor their own symptoms at home and seek help only when their condition worsens. Health workers will no longer call them once a day or supply food and other daily necessities, as they did until last week. Instead, the patients’ family members are now free to go out for essential supplies if they are vaccinated.

Critics have said the government’s new approach disadvantages underprivileged classes, like poor people who lack access to medical care or other social services.

“It’s tantamount to letting the virus spread, rather than doing everything possible to contain its spread,” said ​Woo Seoc-kyun, a representative of the Association of Physicians for Humanism​, a nationwide doctors’ group​. “It threatens to reverse what we have achieved so far through a tight management of the pandemic, like keeping the number of fatalities low.”

The government said that even if the daily caseload soared, ​it would still consider lifting restrictions further so that South Korea could switch to a “life with COVID-19,” treating the disease like seasonal flu, provided that the number of seriously ill patients was kept under control.

Whether the government can keep up with the omicron surge well enough to make such a shift is still up for debate. This week, the United States put South Korea on its “Do Not Travel” list. The number of people being treated at home surged from 150,000 last week to 314,000 on Thursday and is expected to grow.

And so, too, could the number of seriously ill.

Jung Jae-hun, a professor of preventive medicine at Gachon University in South Korea, estimated that the daily caseload would peak at more than 200,000 and stay at that level throughout March. Another estimate, by the government’s National Institute for Mathematical Sciences, predicted as many as 360,000 new patients a day by early next month.

Authorities are preparing more hospital beds for the seriously ill as a precaution. They are also asking neighborhood clinics to pitch in to treat at-home patients remotely. Nearly half of the workers at government-run health clinics in Gyeonggi province, which surrounds Seoul, called for an immediate relief from the “extreme stress” caused by a crushing workload, according to a recent survey.

(Author: Choe Sang-Hun)/(c.2022 The New York Times Company)

New York Times
first published: Feb 18, 2022 10:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347